284 related articles for article (PubMed ID: 26046830)
1. Hyperexpansion of Functional Viral-Specific CD8+ T Cells in Lymphopenia-Associated MCMV Pneumonitis.
Shah PD; Zhong Q; Lendermon EA; Pipeling MR; McDyer JF
Viral Immunol; 2015 Jun; 28(5):255-64. PubMed ID: 26046830
[TBL] [Abstract][Full Text] [Related]
2. CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation.
Simon CO; Holtappels R; Tervo HM; Böhm V; Däubner T; Oehrlein-Karpi SA; Kühnapfel B; Renzaho A; Strand D; Podlech J; Reddehase MJ; Grzimek NK
J Virol; 2006 Nov; 80(21):10436-56. PubMed ID: 16928768
[TBL] [Abstract][Full Text] [Related]
3. Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65).
Morello CS; Cranmer LD; Spector DH
J Virol; 2000 Apr; 74(8):3696-708. PubMed ID: 10729145
[TBL] [Abstract][Full Text] [Related]
4. Strong CD8 T-cell responses following coimmunization with plasmids expressing the dominant pp89 and subdominant M84 antigens of murine cytomegalovirus correlate with long-term protection against subsequent viral challenge.
Ye M; Morello CS; Spector DH
J Virol; 2002 Mar; 76(5):2100-12. PubMed ID: 11836387
[TBL] [Abstract][Full Text] [Related]
5. Control of primary mouse cytomegalovirus infection in lung nodular inflammatory foci by cooperation of interferon-gamma expressing CD4 and CD8 T cells.
Lueder Y; Heller K; Ritter C; Keyser KA; Wagner K; Liu X; Messerle M; Stahl FR; Halle S; Förster R
PLoS Pathog; 2018 Aug; 14(8):e1007252. PubMed ID: 30153311
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic T cells treated with amotosalen prevent lethal cytomegalovirus disease without producing graft-versus-host disease following bone marrow transplantation.
Roback JD; Hossain MS; Lezhava L; Gorechlad JW; Alexander SA; Jaye DL; Mittelstaedt S; Talib S; Hearst JE; Hillyer CD; Waller EK
J Immunol; 2003 Dec; 171(11):6023-31. PubMed ID: 14634114
[TBL] [Abstract][Full Text] [Related]
7. The early kinetics of cytomegalovirus-specific CD8+ T-cell responses are not affected by antigen load or the absence of perforin or gamma interferon.
Andrews DM; Andoniou CE; Fleming P; Smyth MJ; Degli-Esposti MA
J Virol; 2008 May; 82(10):4931-7. PubMed ID: 18337574
[TBL] [Abstract][Full Text] [Related]
8. Memory inflation: continuous accumulation of antiviral CD8+ T cells over time.
Karrer U; Sierro S; Wagner M; Oxenius A; Hengel H; Koszinowski UH; Phillips RE; Klenerman P
J Immunol; 2003 Feb; 170(4):2022-9. PubMed ID: 12574372
[TBL] [Abstract][Full Text] [Related]
9. Memory T cells specific for murine cytomegalovirus re-emerge after multiple challenges and recapitulate immunity in various adoptive transfer scenarios.
Quinn M; Turula H; Tandon M; Deslouches B; Moghbeli T; Snyder CM
J Immunol; 2015 Feb; 194(4):1726-1736. PubMed ID: 25595792
[TBL] [Abstract][Full Text] [Related]
10. Role of the indigenous microbiota in maintaining the virus-specific CD8 memory T cells in the lung of mice infected with murine cytomegalovirus.
Tanaka K; Sawamura S; Satoh T; Kobayashi K; Noda S
J Immunol; 2007 Apr; 178(8):5209-16. PubMed ID: 17404304
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and functional characterization of CD8(+) T cell clones specific for a mouse cytomegalovirus epitope.
Fernandez JA; Zavala F; Tsuji M
Virology; 1999 Mar; 255(1):40-9. PubMed ID: 10049820
[TBL] [Abstract][Full Text] [Related]
12. The specific NK cell response in concert with perforin prevents CD8(+) T cell-mediated immunopathology after mouse cytomegalovirus infection.
Arapović J; Arapović M; Golemac M; Traven L; Tomac J; Rumora D; Ražić E; Krmpotić A; Jonjić S
Med Microbiol Immunol; 2015 Jun; 204(3):335-44. PubMed ID: 25809566
[TBL] [Abstract][Full Text] [Related]
13. Development of a vaccine against murine cytomegalovirus (MCMV), consisting of plasmid DNA and formalin-inactivated MCMV, that provides long-term, complete protection against viral replication.
Morello CS; Ye M; Spector DH
J Virol; 2002 May; 76(10):4822-35. PubMed ID: 11967299
[TBL] [Abstract][Full Text] [Related]
14. Multiple epitopes in the murine cytomegalovirus early gene product M84 are efficiently presented in infected primary macrophages and contribute to strong CD8+-T-lymphocyte responses and protection following DNA immunization.
Ye M; Morello CS; Spector DH
J Virol; 2004 Oct; 78(20):11233-45. PubMed ID: 15452242
[TBL] [Abstract][Full Text] [Related]
15. CD8+ T lymphocytes control murine cytomegalovirus replication in the central nervous system of newborn animals.
Bantug GR; Cekinovic D; Bradford R; Koontz T; Jonjic S; Britt WJ
J Immunol; 2008 Aug; 181(3):2111-23. PubMed ID: 18641350
[TBL] [Abstract][Full Text] [Related]
16. Effect of natural sequence variation at the H-2Ld-restricted CD8+ T cell epitope of the murine cytomegalovirus ie1-encoded pp89 on T cell recognition.
Lyons PA; Allan JE; Carrello C; Shellam GR; Scalzo AA
J Gen Virol; 1996 Oct; 77 ( Pt 10)():2615-23. PubMed ID: 8887498
[TBL] [Abstract][Full Text] [Related]
17. Characterization of virus-induced interferon-gamma responses in mice previously infected with murine cytomegalovirus.
Shanley JD; Shanley JA; Albert G; Biegel D
J Infect Dis; 2001 Mar; 183(5):697-706. PubMed ID: 11181145
[TBL] [Abstract][Full Text] [Related]
18. Viral interference with antigen presentation does not alter acute or chronic CD8 T cell immunodominance in murine cytomegalovirus infection.
Munks MW; Pinto AK; Doom CM; Hill AB
J Immunol; 2007 Jun; 178(11):7235-41. PubMed ID: 17513772
[TBL] [Abstract][Full Text] [Related]
19. Memory Inflation Drives Tissue-Resident Memory CD8
Morabito KM; Ruckwardt TJ; Bar-Haim E; Nair D; Moin SM; Redwood AJ; Price DA; Graham BS
Front Immunol; 2018; 9():1861. PubMed ID: 30154789
[TBL] [Abstract][Full Text] [Related]
20. Nasal peptide vaccination elicits CD8 responses and reduces viral burden after challenge with virulent murine cytomegalovirus.
Gopal IN; Quinn A; Henry SC; Hamilton JD; Staats HF; Frothingham R
Microbiol Immunol; 2005; 49(2):113-9. PubMed ID: 15722596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
